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Abstract
The disproportionate incidences of COVID-19-related hospitalization and mortality for
different age groups and various underlying health conditions is a result of a complex social
predisposition to the exposure, resistance, and tolerance for the infection. Based on the observed
data as well as the molecular mechanisms for viral entry and replication, cellular senescence
related to aging, obesity, hypertension, and diabetes appears to be strongly correlated with the
SARS-CoV-2 infections resulting in higher COVID-19 related complications and mortality.
Establishing such a correlation may allow us to better explain the pathobiology as well as the
differential nature of the SARS-CoV-2 infections and consider targeted control and therapeutic
strategies to combat the disease.
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Introduction
It has become abundantly clear that older adults and individuals with underlying health
conditions such as diabetes, obesity, or heart problems, or smoking are at most risk of serious
complications or death due to COVID-19 1. A recent population-based study by the Center for
Disease Control and Prevention (CDC) using the surveillance network COVID-NET showed that
nearly 75% of all patients hospitalized for COVID-19 during a 4-week period in March 2020 were
aged >50 years 2. Similarly, hospitalization data suggested that males and black population are
disproportionately affected by the disease. Among younger adult (18-64 years) patients, obesity
was the most prevalent underlying condition, followed by hypertension, diabetes, and asthma 2.
The disproportionate incidences of SARS-CoV-2 infections in different age group, race, or gender
is a result of a complex social predisposition to the exposure, resistance, and tolerance for the
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infection. Understanding the molecular mechanisms of how SARS-CoV-2 differentially infects
individuals will allow targeted control and therapeutic strategies to combat the disease. So, why
does COVID-19 disproportionately affect the elderly, obese, and diabetic demographics? Based
on the observed data as well as the molecular mechanisms for viral entry and replication, cellular
senescence related to aging, obesity, and diabetes appears to be strongly correlated with the SARSCoV-2 infections resulting in higher COVID-19 incidences of infections and mortality (Box 1).
This means that these viruses are possibly exploiting the very mechanism intended for eliciting the
immune response for senescent cell removal. Very recently, Malavolta et al.

3

also surveyed

therapeutic molecules targeting senescent cells drawing relevance to COVID-19. This brief review
aims to stimulate the discussion on the potential role of cellular senescence in COVID-19 as well
as other viral infections. Recent reports suggest that some SARS-CoV-2 infected individuals can
harbor the virus for months. The long incubation time and persistence in the body may also be
related to cellular senescence as it is shown that viruses can remain infections for weeks in
senescent cells 4.

Box 1: Correlations of cellular senescence and various underlying conditions implicated in
COVID-19. Many of these conditions and senescence may have feedback to one another and
exacerbate the effects.

Factor

Cellular

COVID-19

Senescence

incidence

Age





Obesity





Type 2 Diabetes





Cigarette Smoking





Hypertension





Cellular senescence
Cellular senescence is a process of irreversible cell-cycle arrest that renders previously
replication-competent cells non-proliferative but still metabolically active 5. A number of factors
such as DNA damage due to oxidative or chemotherapy-induced stress, mitochondrial dysfunction,
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telomere erosion contribute to cellular senescence 6. Normal cells are equipped with repair
mechanisms and the process may include temporary growth arrest. If the repair fails, damaged
cells may either initiate regulated cell death or become senescent. In general, it is a regulated
response to stress and plays important roles in several essential physiological processes, from
regulating bone growth during childhood to wound healing or tissue regeneration after injury and
suppressing tumor progression (see reviews

7,8

). Key features of senescent cells include damage

sensing signaling pathways activation and expression of anti-proliferative molecules resulting in
durable growth arrest. While cellular senescence has important functions, the accumulation of
senescent cells with age is implicated in a number of age-associated conditions, including diabetes
9

as well as cardiovascular

10

and pulmonary diseases

11

. The increase in stress-induced cellular

senescence is a result of cumulative cell damage with age and failure of the immune system to
eliminate them 12. In addition to aging, obesity also leads to an increase in senescent cells 13-15. Fat
tissues acquired from patients with diabetic tissues show characteristics of senescent-like state with
elevated expression of p53 and p21, suggesting that diabetes is associated with cellular senescence
in fat tissue 16. Similarly, hypertension is shown to cause cellular senescence 16,17. Conditions such
as age, obesity, diabetes, and hypertension are, therefore, inter-related and associated with cellular
senescence. Interestingly, all of these conditions are increased risk factors for COVID-19
complications. In addition, one of the primary markers of cellular senescence is leukocyte telomere
shortening

18

, which seems to occur at a differential rate among different demographics, with a

higher rate among men and the black population 19,20.
Senescent cells are tagged with markers that can be recognized by the immune system for
elimination 21. They express factors such as MHC class I polypeptide-related sequence A (MICA)
and UL16 binding protein 2 (ULBP2) which serve as the ligands to bind to the natural killer (NK)
cell receptor NKG2D, thereby activating the cell removal 22,23. This process plays a central role in
tissue remodeling during carcinogenesis and tumor progression. In this respect, senescent cells
don’t just block the cell proliferation but also prime themselves for elimination 24. They also secrete
a plethora of pro-inflammatory cytokines, chemokines, and growth factors, grouped as senescenceassociated secretory phenotype (SASP)

25

. For example, the accumulation of tumor suppressor

molecules p16INK4a and P53 are key markers of senescent cells.
In addition to the NK cell and macrophages, other innate and adaptive immune systems are
also suggested to play a role in senescent cell surveillance. For example, the adaptive response to
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oncogene-induced senescent cells involves T cells (CD4) and MHC class II molecules on the cell
surface 26,27. Similarly, IgM antibodies are able to recognize senescent cells by binding to surfaceexposed molecules, including an oxidized form of vimentin filament presented on the outer surface
of senescent cells

28

, suggesting the availability of a variety of new antigens presented on the

senescent cell surface for immune system recognition and elimination 24. Therefore, reduction in
immune clearance in immunosuppressive conditions due to aging results in the accumulation of
senescent cells.

Viral infections and the role of cellular senescence
Cellular senescence appears to play a dual or differential role in infections by different
viruses. While cellular senescence is implied in impaired viral infection and is considered to be an
important protection mechanism against oncogenic virus effects

29,30

, it is also suggested to

enhance viral replication 31. Persistent viral or oncogenic stresses preferentially induce senescence
in normal cells. In response to viral infection, cells produce a high concentration of α and βinterferon cytokines localized in the sites of infection 32. It is shown that normal cells can turn into
senescent cells upon prolonged treatment with β-interferon leading to activation of DNA-damage
signaling and p53 tumor suppressor 33. Cytokines secreted by the infection-induced senescent cells
can further encourage senescence in normal neighboring cells thereby stimulating immune
response 34 and potentially conferring protection from infection. It has been shown that senescent
cells are resistant to vesicular stomatitis virus (VSV) infection and replication in vivo 29, likely due
to the recruitment of the immune system mediated by SASP molecules. Several viruses, including
Hepatitis B virus (HBV) X 35, Simian virus-40 (SV40) 36, and Human Papillomaviruses (HPV) 37
have developed mechanisms to either bypass or defeat cellular senescence for efficient viral
replication. However, the role of cellular senescence appears to be more complicated. For example,
it is found that the influenza virus (IFV) and the Varicella Zoster virus (VZV) replicate more
efficiently in senescent cells than normal cells due to the incompetence of senescent cells in
controlling the replication

31

. In addition, either knockdown of anti-senescent gene sirtuin 1

(SIRT1) in normal primary human epithelial and fibroblast cells, or the inhibition of SIRT1
activities by its inhibitor nicotinamide, enhanced viral replication, providing further evidence that
senescent cells lacking SIRT1 can accelerate IFV replication 31.
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Potential Role of senescence on molecular mechanisms of coronavirus infections
Although our understanding of how SARS-CoV-2 exploits cellular senescence is still
lacking, a multitude of studies on the coronavirus entry as well as the features of the senescent
cells provide a strong ground that cellular senescence plays an indispensable role in virus particle
attachment on the host cell surface and infection. A few specifics that connect the related viral
infections to cellular senescence and their relevance to SARS-CoV-2 are given below.

Efficient SARS-CoV and Enterovirus 71 (EV71) infections require surface Vimentin, which is a
key component of the senescent cell surface.
It has recently been shown that senescent lung fibroblasts express and expose an oxidized
form of membrane-bound vimentin on their cell surface 28, and therefore the cell-surface vimentin
is a novel marker for senescent fibroblasts. The ability of the IgM isotype of the innate immune
system to recognize and bind the cell surface vimentin suggests that the oxidized membrane-bound
vimentin is likely presented on the surface by the senescent cells for their removal by the immune
system. Failure to remove senescent cells due to impaired immune system results in the
accumulation of these vimentin-rich senescent cell surfaces, and some viruses, including SARSCoV and Enterovirus 71 (EV71) have found ways to exploit this.
SARS-CoV and SARS-CoV-2 spike proteins utilize the angiotensin-converting enzyme 2
(ACE2) as the receptor to latch on host cell surface. Other receptors such as the C-type lectin
(CD209L) also facilitate the viral entry

38

. A recent study showed that the formation of spike

protein-ACE2 is not sufficient for the SARS-CoV entry to infect the host cells and that surface
vimentin is also required 39. This study suggested that the cell surface vimentin directly interacts
with the SARS-CoV spike protein during viral entry. Along with SARS-CoV, surface vimentin
has also been shown to be an attachment receptor for EV71 40 as well as for endothelial infection
by Cowpea mosaic virus (CPMV) 41. Cells pretreated with vimentin fragments resulted in lower
virus yields as it competitively inhibited the EV71 infection 40. Based on the requirement of surface
vimentin for viral entry of SARS-CoV and other viruses and the abundance of exposed surface
vimentin in senescent cells, it is prudent to hypothesize that cellular senescence plays an essential
role in SARS-CoV-2 infection (Fig. 1A). It is yet unknown whether the exposed cell surface
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vimentin interacts with the receptor-binding domain or the fusion core helices. It is also not known
clearly which domain of vimentin is utilized.

Figure 1. A) Initiation of SARS-CoV-2 entry by latching onto ACE2. Surface exposed oxidized
form of vimentin in senescence cells may play a role in the viral entry 39 (or stabilization at the
surface). It is not known if and how DPP4 affects the viral entry. B) SARS-CoV-2 RBD overlapped
with the MERS-CoV RBD complexed with DPP4 shows a significant steric clash with DPP4,
suggesting that binding with DPP4 may only occur via a conformational rearrangement of the
RBD region.

MERS-CoV spike protein binds with DPP4, a key receptor that is abundantly expressed in
senescent cells
In an attempt to find novel senescent cell surface markers on the plasma-membrane, a
recent study used Mass Spectrometry to survey membrane- and cell surface-associated proteins
and found that Dipeptidyl peptidase 4 (DPP4) is the most abundant membrane-bound protein
localized on the plasma-membrane surface

42

. In fact, normal proliferating cells showed

senescence upon overexpression of DPP4, confirmed by the elevated levels of senescence markers
p16 and p21, and decrease in anti-senescent marker SIRT1. Importantly, DPP4 is involved in the
regulation of glucose level that results in the reduction in insulin secretion, abnormal metabolism
of visceral adipose tissues, and the increase in inflammation in type 2 diabetes.
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Human DPP4 is a known host-cell receptor for the spike protein of Middle East respiratory
43,44

syndrome coronavirus (MERS-CoV)

. DPP4 mediated immune response dysfunction is

implicated in the higher rate of mortality and complications for type 2 diabetes infected with
MERS-CoV. Although the effects of DPP4 inhibition is still not clearly understood, DPP4 is
considered a potential therapeutic and vaccine target for type 2 diabetes 45,46. While SARS-CoV is
closely related to MERS-CoV, SARS-CoV and SARS-CoV-2 primarily attach to ACE2 instead of
DPP4. It is not yet known whether DPP4 is SARS-CoV-2 However, given the high and
disproportionate incidence of COVID-19 complications among people with diabetes, it is likely
that DPP4 plays a role in SARS-CoV-2

47

. The structure comparison of the SARS-CoV-2 RBD

with the MERS-CoV RBD complexed with DPP4 shows that SARS-CoV-2 structural overlap with
DPP4 (Fig. 1B). However, a conformational rearrangement in the RBD overlapping region may
still allow binding with DPP4. Consequently, a clinical trial is underway to study the effects of
DPP4 inhibitor Linagliptin on type-2 diabetic individuals infected with COVID-1948.
In addition to these receptors, other human coronaviruses, including those yet unknown to
us, may utilize different receptors for attaching to the human host cells. Besides viral entry,
efficient use of host cell machinery is critical for the virus to replicate and egress, and senescence
may play a role during any stage of the viral life-cycle. For example, overproduction of vimentin
leads to cellular senescence

49

, and cellular vimentin is found to regulate replication and virion

assembly of myriads of viruses including the Dengue virus, Influenza A virus

50

, HIV

51

and

Human Enterovirus Group B virus 52, and Bluetongue virus 53.

Senescence in the respiratory system
Cellular senescence has increasingly been implicated in aging lungs as well as lungs with
conditions such as chronic obstructive pulmonary diseases (COPD), idiopathic pulmonary fibrosis
(IPF), and asthma

54,55

. Bronchial and alveolar epithelial cells can develop senescence due to a

number of assaults such as smoking, microbial infections, and pollution. Although development
of senescence is part of the lung repair mechanism, continuous exposure to the stress factors can
result in excessive cellular senescence causing several chronic conditions 56,57. As such, cigarette
smoking is known to cause epithelial inflammation with increased p16 activities in the airways
with increased p16 activity and is a major causal factor in COPD pathologies 58.
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Further outlook
In summary, this brief review aims to explore the potential role cellular senescence plays
in the disparity observed in COVID-19 infection. Mortality. aging, as well as various conditions
such as obesity, diabetes, and hypertension, are intricately related to cellular senescence, and
individuals with any of these conditions are at increased risk of COVID-19 complications.
Molecular mechanisms of the viral entry point to the utilization of key receptors that are also
markers of senescent cells. The high correlation of the COVID-19 disparity to cellular senescence
makes a compelling case to explore it further in this light. Establishing the connection may allow
us to explain the disease pathobiology. For example, senescent cells can harbor virus particles that
remain infectious for a long time, resulting in longer incubation times, as happens with HPV-16
virions that remain infectious for 2 weeks on senescent cells 4. This may also help explain the
persistence of the virus for months after infection. The relevance of coronavirus infections with
senescence will also allow us to target cellular senescence by therapeutics or by boosting immune
recognition of senescent cells 3,7,59. Ultimately, understanding the molecular mechanisms of how
SARS-CoV-2 differentially infects individuals will allow targeted control and combinationtherapeutic strategies to fight off the infection and save lives.
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